Age-related hearing loss is a multifactor-origin disease which affects almost one out of three people aged between 65 and 74.
Researchers find the expression of an amino acid transporter in age-related hearing loss
10th charity wine tasting in support of research into cancer and metastasis at IRB Barcelona
Genes activated in metastasis also drive the first stages of tumour growth
Ernest Giralt: "There are many diseases caused by failures in the protein-protein interactions”
On Sunday 25 February, the non-profit organisation “Vi per Vida” (Wine for Life), will be holding a new wine-tasting event for 300 people at the Llobet i Gurí Factory in Calella (Barcelona).
In cancer research, there has been a tendency to differentiate between the genes responsible for tumour development and those that give rise to metastasis and to study these processes separately si
The chemist Ernest Giralt (Viladecans, 1948) is the head of the Peptides a
La Vanguardia, EFE, La Sexta, RTVE, among other media, have published articles about the study by Jordi Casanova, at IRB Barcelona, that reveals that the same genes can activate tumour growth and metastasis and that therefore some tumours are conferred metastatic capacity from their very outset.
The newspaper El Periódico has published an interview with Dani Infante, a physicist and cancer patient who organised the event "Al càncer, Donem-li recerca!" on the occasion of International Childhood Cancer Day.
TV3, RTVE, Rac1, La Vanguardia, and Ara, among other important media, have published articles about research led by Eduard Batlle, head of the Colorectal Cancer Laboratory at IRB Barcelona, on the effectiveness of treatments that enhance immune system function in colon cancer.
Felice Alessio Bava
IRB Barcelona Alumni member
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Quick facts about IRB
IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.